<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://doctorsonly.co.il/2019/12/167047/"/>
    <meta property="og:site_name" content="Doctors Only"/>
    <meta property="article:published_time" content="2019-12-09T15:00:00+00:00"/>
    <meta property="og:title" content="Highlights from Prof Fagiolini lecture - Israel, May 2019"/>
    <meta property="og:description" content="הרצאתו של פרופ' פג'יוליני, על טיפול בדיכאון, תל אביב, 5 במאי, 2019"/>
  </head>
  <body>
    <article>
      <h1>Highlights from Prof Fagiolini lecture - Israel, May 2019</h1>
      <h2>הרצאתו של פרופ' פג'יוליני, על טיפול בדיכאון, תל אביב, 5 במאי, 2019</h2>
      <address><time datetime="2019-12-09T15:00:00+00:00">09 Dec 2019, 15:00</time> by <a rel="author">מערכת דוקטורס אונלי</a></address>
      <p>Treatment of depression, which has traditionally only focused on depressive symptoms in general, should target all three domains (emotional, cognitive and physical) to increase the chances of functional recovery.</p>
      <p>Clinical Practice indicates that:</p>
      <p>1. There is not a medication that is always better than the others for each and any patient<br/>2. Antidepressants are profoundly different in terms of ability to work for specific patients and specific symptoms<br/>3. Antidepressants are different in terms of tolerability and side effects profile<br/><i>4. Vortioxetine</i> is an effective, safe, effective and well tolerated medication, able to work well on mood, cognition, executive functions, interests, motivation, energy, and neurovegetative functions</p>
      <p>
        <b>Comparative efficacy and acceptability of 21 antidepressants of the acute treatment of MDD (Cipriani, The Lancet 2018)</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/339991853?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>
        <b>Vortioxetine/ Brintellix MOA</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/339991938?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>
        <b>Getting well but not getting better: Vortioxetine and Cognition</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/339991990?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>
        <b>Functionality improvement: why is so important? The role of Vortioxetine</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/339992019?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>
        <b>New Data on emotional blunting</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/339992041?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>
        <b>Depression is a complex disease with many unmet needs</b>
      </p>
      <figure>
        <iframe src="https://player.vimeo.com/video/341583437?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
      <p>להרצאה המלאה:</p>
      <figure>
        <iframe src="https://player.vimeo.com/video/335196006?app_id=122963" width="640" height="360" data-service="Vimeo" scrolling="no"/>
      </figure>
    </article>
  </body>
</html>